Is the Eclipx Group share price in the buy zone yet?

The Eclipx Group Ltd (ASX: ECX) share price fell 56% after a negative ASX update before rebounding to $1.24 per share at market close – is it in the buy zone?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Eclipx Group Ltd (ASX: ECX) share price fell 56% in one day to $0.57 per share after a negative ASX update before rebounding to $1.24 per share at market close – but is it in the buy zone?

a woman

What happened to Eclipx to start the year?

In mid-March this year, Eclipx emerged from its trading halt with an update announcing a 42.4% decrease in net profit after tax and adjustments (NPATA), compared to the first five months of FY18.

The company also announced that its financial performance had "softened" since its 29 January 2019 update as its Grays Industrial and Insolvency segments continued to underperform, and that it was looking at divesting non-core assets.

Both Eclipx management and McMillan Shakespeare Limited (ASX: MMS) announced that a planned merger was "unlikely" as McMillan pointed to several key issues in Eclipx's trading update, including the NPATA decline and ongoing underperformance.

Could the Eclipx share price be in the buy zone?

I'm not personally in the game of distressed investing, but so far Eclipx looks like it might be back in the buy zone.

If you had managed to buy in the dip immediately following the crash, you would have netted yourself a tidy 117% profit in just a few months, which is greater than the share price performance of Afterpay Touch Group Ltd (ASX: APT) or Appen Ltd (ASX: APX) over the last 6 months.

Eclipx management has made a few structural changes and look to be plotting a path back to profitability, after non-cash impairment of assets and a change of senior leadership (including the CFO) in the subsequent months.

Eclipx's first-half earnings (released at the end of May) were indicative of the difficult 6 months the company has endured, but if market conditions hold and the company can stick to its strategy, I think the full-year accounts could show improved performance and a share price rebound for brave investors.

Motley Fool contributor Lachlan Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »